To test this hypothesis, we set out to undertake a new context to determine the gene expression of PPAR-γ2, C/EBP-α and FOXO1 from morbidly obese individuals with high and low insulin resistance in VAT, to understand their association with obesity and insulin resistance. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.